新冠疫苗接种后SARS-CoV-2再感染风险降低——肯塔基州,2021年5-6月
该报告基于2021年5-6月肯塔基州2020年既往感染SARS-CoV-2者的病例对照评估,分析疫苗接种与再感染的关联。未接种者再感染 odds 是完全接种者的2.34倍(OR=2.34;95%CI=1.58-3.47)。提示既往感染者完成接种可提供额外保护,所有符合条件者均应接种。
要点
- 既往SARS-CoV-2感染者未接种疫苗再感染 odds 为完全接种者的2.34倍(95%CI 1.58-3.47)。
- 既往感染者完成新冠疫苗接种可获得额外再感染保护。
- 所有符合条件者均应接种疫苗,即使既往感染过SARS-CoV-2。
核心结论
- 既往SARS-CoV-2感染者中,完全接种疫苗与再感染风险降低相关。
研究设计与样本
- 2021年5-6月肯塔基州2020年既往感染SARS-CoV-2者的病例对照评估,分析疫苗接种与再感染的关联。
主要发现
- 未接种疫苗的肯塔基州居民再感染 odds 是完全接种者的2.34倍(OR=2.34;95%CI=1.58-3.47)。
临床怎么用
- 对所有符合条件者均应提供疫苗接种,即使其既往已感染SARS-CoV-2。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although laboratory evidence suggests that antibody responses following COVID-19 vaccination provide better neutralization of some circulating variants than does natural infection (1,2), few real-world epidemiologic studies exist to support the benefit of vaccination for previously infected persons. This report details the findings of a case-control evaluation of the association between vaccination and SARS-CoV-2 reinfection in Kentucky during May-June 2021 among persons previously infected with SARS-CoV-2 in 2020. Kentucky residents who were not vaccinated had 2.34 times the odds of reinfection compared with those who were fully vaccinated (odds ratio [OR] = 2.34; 95% confidence interval [CI] = 1.58-3.47). These findings suggest that among persons with previous SARS-CoV-2 infection, full vaccination provides additional protection against reinfection. To reduce their risk of infection, all eligible persons should be offered vaccination, even if they have been previously infected with SARS-CoV-2.
引用
- Cavanaugh AM, Spicer KB, Thoroughman D, et al. Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34383732. doi:10.15585/mmwr.mm7032e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。